AORT
Price
$26.30
Change
+$0.38 (+1.47%)
Updated
Oct 4, 02:33 PM (EDT)
27 days until earnings call
SIBN
Price
$14.16
Change
+$0.31 (+2.24%)
Updated
Oct 4, 10:21 AM (EDT)
31 days until earnings call
Ad is loading...

AORT vs SIBN

Header iconAORT vs SIBN Comparison
Open Charts AORT vs SIBNBanner chart's image
Artivion
Price$26.30
Change+$0.38 (+1.47%)
Volume$1.01K
CapitalizationN/A
SI-BONE
Price$14.16
Change+$0.31 (+2.24%)
Volume$200
CapitalizationN/A
View a ticker or compare two or three
AORT vs SIBN Comparison Chart
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AORT vs. SIBN commentary
Oct 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a StrongBuy and SIBN is a Sell.

COMPARISON
Comparison
Oct 04, 2024
Stock price -- (AORT: $25.92 vs. SIBN: $13.85)
Brand notoriety: AORT and SIBN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 77% vs. SIBN: 189%
Market capitalization -- AORT: $873.56M vs. SIBN: $672.23M
AORT [@Medical Specialties] is valued at $873.56M. SIBN’s [@Medical Specialties] market capitalization is $672.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileSIBN’s FA Score has 0 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • SIBN’s FA Score: 0 green, 5 red.
According to our system of comparison, SIBN is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 5 TA indicator(s) are bullish while SIBN’s TA Score has 4 bullish TA indicator(s).

  • AORT’s TA Score: 5 bullish, 4 bearish.
  • SIBN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, AORT is a better buy in the short-term than SIBN.

Price Growth

AORT (@Medical Specialties) experienced а +0.62% price change this week, while SIBN (@Medical Specialties) price change was +0.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.78%. For the same industry, the average monthly price growth was +3.71%, and the average quarterly price growth was -3.88%.

Reported Earning Dates

AORT is expected to report earnings on Oct 31, 2024.

SIBN is expected to report earnings on Nov 04, 2024.

Industries' Descriptions

@Medical Specialties (-1.78% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($874M) has a higher market cap than SIBN($672M). AORT YTD gains are higher at: 44.966 vs. SIBN (-34.016). AORT has higher annual earnings (EBITDA): 26.8M vs. SIBN (-34.45M). SIBN has more cash in the bank: 166M vs. AORT (58.9M). SIBN has less debt than AORT: SIBN (39M) vs AORT (358M). AORT has higher revenues than SIBN: AORT (354M) vs SIBN (139M).
AORTSIBNAORT / SIBN
Capitalization874M672M130%
EBITDA26.8M-34.45M-78%
Gain YTD44.966-34.016-132%
P/E Ratio434.78N/A-
Revenue354M139M255%
Total Cash58.9M166M35%
Total Debt358M39M918%
FUNDAMENTALS RATINGS
AORT vs SIBN: Fundamental Ratings
AORT
SIBN
OUTLOOK RATING
1..100
1666
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9095
PRICE GROWTH RATING
1..100
4464
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SIBN's Valuation (45) in the Medical Specialties industry is somewhat better than the same rating for AORT (93). This means that SIBN’s stock grew somewhat faster than AORT’s over the last 12 months.

SIBN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AORT (100). This means that SIBN’s stock grew similarly to AORT’s over the last 12 months.

AORT's SMR Rating (90) in the Medical Specialties industry is in the same range as SIBN (95). This means that AORT’s stock grew similarly to SIBN’s over the last 12 months.

AORT's Price Growth Rating (44) in the Medical Specialties industry is in the same range as SIBN (64). This means that AORT’s stock grew similarly to SIBN’s over the last 12 months.

AORT's P/E Growth Rating (84) in the Medical Specialties industry is in the same range as SIBN (100). This means that AORT’s stock grew similarly to SIBN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTSIBN
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 22 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AORT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SIBN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFGRX52.290.01
+0.02%
Commerce Growth
HNTVX51.69N/A
N/A
Heartland Value Institutional
PGEMX25.82-0.05
-0.19%
George Putnam Balanced M
LCEVX19.31-0.10
-0.52%
Invesco Diversified Dividend C
MSJIX16.75-0.14
-0.83%
Morgan Stanley Global Endurance I

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with WAT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-1.63%
WAT - AORT
46%
Loosely correlated
-0.18%
A - AORT
44%
Loosely correlated
-1.36%
SIBN - AORT
42%
Loosely correlated
+1.84%
KIDS - AORT
41%
Loosely correlated
-0.89%
LMAT - AORT
41%
Loosely correlated
-0.27%
More

SIBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SIBN has been loosely correlated with KIDS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SIBN jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIBN
1D Price
Change %
SIBN100%
+1.84%
KIDS - SIBN
52%
Loosely correlated
-0.89%
FNA - SIBN
46%
Loosely correlated
-4.87%
QTRX - SIBN
45%
Loosely correlated
-4.88%
LUNG - SIBN
45%
Loosely correlated
-1.75%
UTMD - SIBN
44%
Loosely correlated
-0.47%
More